Fulgent Genetics to Announce Second Quarter 2019 Financial Results on Monday August 5, 2019
July 22 2019 - 8:00AM
Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the
“company”) today announced that it will release its second quarter
2019 financial results after the market closes on Monday August 5,
2019. The company’s Chairman and Chief Executive Officer Ming Hsieh
and its Chief Financial Officer Paul Kim will host a conference
call for the investment community the same day at 4:30 PM ET (1:30
PM PT) to discuss the results and answer questions.
The call can be accessed through a live audio
webcast in the Investors section of the company’s website,
http://ir.fulgentgenetics.com, and through a live conference call
by dialing (855) 321-9535 using the conference ID 1283176. An audio
replay will be available in the Investors section of the company’s
website or by calling (855) 859-2056 using passcode 1283176 through
August 12, 2019.
About Fulgent Genetics
Fulgent Genetics is a technology company with a
focus on offering comprehensive genetic testing to provide
physicians with clinically actionable diagnostic information they
can use to improve the quality of patient care. The company has
developed a proprietary technology platform that allows it to offer
a broad and flexible test menu and continually expand and improve
its proprietary genetic reference library, while maintaining
accessible pricing, high accuracy and competitive turnaround times.
The company believes its test menu offers more genes for testing
than its competitors in today’s market, which enables it to provide
expansive options for test customization and clinically actionable
results.
Investor Relations Contacts:The
Blueshirt GroupNicole Borsje, 415-217-2633,
nborsje@blueshirtgroup.com
Fulgent Genetics (NASDAQ:FLGT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Fulgent Genetics (NASDAQ:FLGT)
Historical Stock Chart
From Apr 2023 to Apr 2024